A Nitric Oxide-Donating Statin Decreases Portal Pressure with a Better Toxicity Profile than Conventional Statins in Cirrhotic Rats
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Nitric Oxide-Donating Statin Decreases Portal Pressure with a Better Toxicity Profile than Conventional Statins in Cirrhotic Rats
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-01-13
DOI
10.1038/srep40461
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Statins Are Associated With a Decreased Risk of Decompensation and Death in Veterans With Hepatitis C–Related Compensated Cirrhosis
- (2016) Arpan Mohanty et al. GASTROENTEROLOGY
- Effect of addition of statins to antiviral therapy in hepatitis C virus-infected persons: Results from ERCHIVES
- (2015) Adeel A. Butt et al. HEPATOLOGY
- Statin use and non-alcoholic steatohepatitis in at risk individuals
- (2015) Paola Dongiovanni et al. JOURNAL OF HEPATOLOGY
- Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis
- (2015) John Chen Hsiang et al. JOURNAL OF HEPATOLOGY
- Statin use and the risk of cirrhosis development in patients with hepatitis C virus infection
- (2015) Yao-Hsu Yang et al. JOURNAL OF HEPATOLOGY
- Statins and liver disease: from concern to 'wonder' drugs?
- (2015) Jaume Bosch et al. Nature Reviews Gastroenterology & Hepatology
- Statins activate the canonical hedgehog-signaling and aggravate non-cirrhotic portal hypertension, but inhibit the non-canonical hedgehog signaling and cirrhotic portal hypertension
- (2015) Frank E. Uschner et al. Scientific Reports
- The renal effects of droxidopa are maintained in propranolol treated cirrhotic rats
- (2014) Sarai Rodríguez et al. LIVER INTERNATIONAL
- Rho/Rho-Associated Coiled-Coil Forming Kinase Pathway as Therapeutic Targets for Statins in Atherosclerosis
- (2013) Naoki Sawada et al. ANTIOXIDANTS & REDOX SIGNALING
- Statins as Regulators of Redox State in the Vascular Endothelium: Beyond Lipid Lowering
- (2013) Marios Margaritis et al. ANTIOXIDANTS & REDOX SIGNALING
- Nitric Oxide-Donating Atorvastatin Attenuates Neutrophil Recruitment During Vascular Inflammation Independent of Changes in Plasma Cholesterol
- (2013) Roberta Baetta et al. CARDIOVASCULAR DRUGS AND THERAPY
- Mechanisms of the Statins Cytotoxicity in Freshly Isolated Rat Hepatocytes
- (2013) Narges Abdoli et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- Nitric oxide enhances the anti-inflammatory and anti-atherogenic activity of atorvastatin in a mouse model of accelerated atherosclerosis
- (2012) Stefania Momi et al. CARDIOVASCULAR RESEARCH
- Effects of simvastatin administration on rodents with lipopolysaccharide-induced liver microvascular dysfunction
- (2012) Vincenzo La Mura et al. HEPATOLOGY
- Functional aspects on the pathophysiology of portal hypertension in cirrhosis
- (2012) Juan-Carlos García-Pagán et al. JOURNAL OF HEPATOLOGY
- The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial–stellate cell deactivation induced by statins
- (2012) Giusi Marrone et al. JOURNAL OF HEPATOLOGY
- Atorvastatin inhibits proliferation and apoptosis, but induces senescence in hepatic myofibroblasts and thereby attenuates hepatic fibrosis in rats
- (2012) Sabine Klein et al. LABORATORY INVESTIGATION
- Nitric oxide prevents atorvastatin-induced skeletal muscle dysfunction and alterations in mice
- (2012) Giuseppe D'Antona et al. MUSCLE & NERVE
- Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD
- (2012) Marcos Pasarín et al. PLoS One
- Role of Differentiation of Liver Sinusoidal Endothelial Cells in Progression and Regression of Hepatic Fibrosis in Rats
- (2011) Guanhua Xie et al. GASTROENTEROLOGY
- Yes! Statins can be given to liver patients
- (2011) Ted Bader JOURNAL OF HEPATOLOGY
- Hepatotoxicity associated with statins: Reports of idiosyncratic liver injury post-marketing
- (2011) Einar Björnsson et al. JOURNAL OF HEPATOLOGY
- Endothelial expression of transcription factor Kruppel-like factor 2 and its vasoprotective target genes in the normal and cirrhotic rat liver
- (2010) J. Gracia-Sancho et al. GUT
- Atorvastatin attenuates hepatic fibrosis in rats after bile duct ligation via decreased turnover of hepatic stellate cells
- (2010) Jonel Trebicka et al. JOURNAL OF HEPATOLOGY
- Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial
- (2009) Juan G. Abraldes et al. GASTROENTEROLOGY
- Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis
- (2009) Guadalupe Garcia-Tsao et al. HEPATOLOGY
- Simvastatin effects on portal-systemic collaterals of portal hypertensive rats
- (2009) Hui-Chun Huang et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Drug-Induced Liver Injury Associated with Statins
- (2009) Mark Russo et al. SEMINARS IN LIVER DISEASE
- Atorvastatin attenuates angiotensin II-induced inflammatory actions in the liver
- (2008) Montserrat Moreno et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- The management of portal hypertension: Rational basis, available treatments and future options
- (2008) Jaime Bosch et al. JOURNAL OF HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started